Page last updated: 2024-08-16

propidium and imatinib mesylate

propidium has been researched along with imatinib mesylate in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andreu, EJ; de Alava, E; Fernández-Luna, JL; Fontalba, A; Gaboli, M; González, I; Inogés, S; Martín-Algarra, S; Panizo, A; Pardo, J; Prósper, F; Sierrasesúmaga, L	1
Aaberg-Jessen, C; Christensen, KG; Jensen, PH; Jensen, SS; Kolenda, J; Kristensen, BW; Nørregaard, A; Schrøder, HD	1

Other Studies

2 other study(ies) available for propidium and imatinib mesylate

Article	Year
Imatinib inhibits proliferation of Ewing tumor cells mediated by the stem cell factor/KIT receptor pathway, and sensitizes cells to vincristine and doxorubicin-induced apoptosis. Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Jan-15, Volume: 10, Issue:2 Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Benzamides; Blotting, Western; Bone Neoplasms; Cell Division; Cell Line, Tumor; Dose-Response Relationship, Drug; Doxorubicin; Enzyme Inhibitors; Flow Cytometry; Humans; Imatinib Mesylate; Immunohistochemistry; Indicators and Reagents; Inhibitory Concentration 50; Ligands; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Phosphorylation; Piperazines; Precipitin Tests; Propidium; Proto-Oncogene Proteins c-kit; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sarcoma, Ewing; Signal Transduction; Stem Cell Factor; Vincristine	2004
Effects of chemotherapeutics on organotypic corticostriatal slice cultures identified by a panel of fluorescent and immunohistochemical markers. Neurotoxicity research, 2012, Volume: 22, Issue:1 Topics: Animals; Antineoplastic Agents; Benzamides; Biomarkers; Carrier Proteins; Cell Death; Dacarbazine; Glial Fibrillary Acidic Protein; Imatinib Mesylate; Immunohistochemistry; Indicators and Reagents; Microtubule-Associated Proteins; Neuroglia; Neurons; Nimustine; Piperazines; Propidium; Pyrimidines; Rats; Temozolomide; Vincristine	2012

Article

Year

Imatinib inhibits proliferation of Ewing tumor cells mediated by the stem cell factor/KIT receptor pathway, and sensitizes cells to vincristine and doxorubicin-induced apoptosis.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Jan-15, Volume: 10, Issue:2

Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Benzamides; Blotting, Western; Bone Neoplasms; Cell Division; Cell Line, Tumor; Dose-Response Relationship, Drug; Doxorubicin; Enzyme Inhibitors; Flow Cytometry; Humans; Imatinib Mesylate; Immunohistochemistry; Indicators and Reagents; Inhibitory Concentration 50; Ligands; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Phosphorylation; Piperazines; Precipitin Tests; Propidium; Proto-Oncogene Proteins c-kit; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sarcoma, Ewing; Signal Transduction; Stem Cell Factor; Vincristine

2004

Effects of chemotherapeutics on organotypic corticostriatal slice cultures identified by a panel of fluorescent and immunohistochemical markers.

Neurotoxicity research, 2012, Volume: 22, Issue:1

Topics: Animals; Antineoplastic Agents; Benzamides; Biomarkers; Carrier Proteins; Cell Death; Dacarbazine; Glial Fibrillary Acidic Protein; Imatinib Mesylate; Immunohistochemistry; Indicators and Reagents; Microtubule-Associated Proteins; Neuroglia; Neurons; Nimustine; Piperazines; Propidium; Pyrimidines; Rats; Temozolomide; Vincristine

2012